In analyzing correlations between ADAMTS14 expression and clinicopathological features, we found that negative cytoplasmic expression of ADAMTS14 was significantly associated with higher frequencies of lymph node metastasis and more advanced AJCC stages (III/IV). This evidence concerns the gene ADAMTS14 and metastatic malignant neoplasm in the lymph nodes.